Jude is a member of MyMD’s Board of Directors, and chairs the Nomination Committee. He also serves as Chief Business Officer at 54gene, Inc, a Washington DC-based venture-backed, clinical-stage biopharmaceutical. Prior to joining MYMD’s Board, Jude worked as a transaction and strategy adviser for over 20 years across life sciences and industrial markets.
Jude’s work involved advising clients on growth strategy choices in the context of rapidly evolving ecosystems. From a transaction perspective, Jude has advised clients on identifying investment targets, building financial models and forecasts, negotiating licensing and co-development agreements, and conducting commercial due diligence in support of M&A and joint venture activity. Jude has deep working experience across multiple continents with a variety of sovereign, regional government, philanthropic, and corporate clients.
Jude has served in several senior roles in consulting, industry, government, and philanthropy, including with ZS Associates, IQVIA, Inc., EY-Parthenon, Bain & Company, the Bill & Melinda Gates Foundation, AgencyRx/DDB, Overseas Shipholding Group, and Monitor Group (now Monitor Deloitte). Jude also served as an adviser and founding Managing Director for Nirsal Plc, a wholly-owned subsidiary of the Central Bank of Nigeria. Jude presently serves on the Board of Directors of a privately held African specialty food and snacks manufacturer, Bonita Foods. Jude graduated from Swarthmore College with a double Honors B.A. in Economics and Political Science.